Understanding how cells respond to DNA replication stress
Structural Biology of the DNA Replication Stress Response
This study is looking at how cells fix problems that can happen when they copy their DNA, which is important for preventing cancer, and the findings could help create better treatments for patients.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-10840364 on NIH RePORTER |
What this research studies
This research investigates the mechanisms by which cells manage challenges during DNA replication that can lead to genomic instability, a key factor in cancer development. The team aims to uncover how specific proteins and multi-protein complexes work together to stabilize and restart damaged DNA replication forks. By using advanced techniques such as structural biology and biochemistry, the research will focus on three critical processes that help cells cope with DNA damage. Patients may benefit from insights gained into these processes, which could lead to improved cancer treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with cancers associated with genomic instability or DNA repair deficiencies.
Not a fit: Patients with cancers that do not involve DNA replication stress or those with unrelated health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for enhancing DNA repair mechanisms in cancer cells, potentially improving treatment outcomes.
How similar studies have performed: Previous research has shown promising results in understanding DNA repair mechanisms, indicating that this approach has the potential for significant breakthroughs.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Eichman, Brandt F — Vanderbilt University
- Study coordinator: Eichman, Brandt F
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.